
-
2012
Company Description
Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment
Emerge Diagnostics has developed an FDA-registered, class-II diagnostic device called an Electrodiagnostic Functional Assessment (EFA) that can age and evaluate muscle activity, distinguish between acute versus chronic injury, and objectively quantify effort.
-
Manufacturer:
Science and Engineering -
Formed:
2012 -
Founders:
Phil Reaston -
Company Website:
-
Company E-mail:
-
Company Address:
5924 Balfour Ct., Suite 102Carlsbad, CAUnited States -
CEO:
- Phil Reaston
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits